Smith Moore & CO. grew its holdings in Centene Co. (NYSE:CNC – Free Report) by 6.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 5,349 shares of the company’s stock after buying an additional 339 shares during the quarter. Smith Moore & CO.’s holdings in Centene were worth $324,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of CNC. Capital Advisors Ltd. LLC boosted its stake in shares of Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after buying an additional 177 shares during the period. Rialto Wealth Management LLC purchased a new position in Centene in the fourth quarter worth approximately $30,000. OFI Invest Asset Management acquired a new position in Centene during the 4th quarter worth approximately $33,000. SRS Capital Advisors Inc. increased its position in shares of Centene by 73.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock valued at $38,000 after purchasing an additional 267 shares during the last quarter. Finally, Riverview Trust Co raised its holdings in shares of Centene by 172.7% in the 4th quarter. Riverview Trust Co now owns 758 shares of the company’s stock valued at $46,000 after purchasing an additional 480 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.
Centene Stock Performance
Shares of CNC stock opened at $62.13 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. The stock has a 50 day simple moving average of $59.72 and a 200-day simple moving average of $62.26. The company has a market cap of $30.82 billion, a price-to-earnings ratio of 9.96, a price-to-earnings-growth ratio of 0.80 and a beta of 0.40. Centene Co. has a 12-month low of $55.03 and a 12-month high of $80.59.
Wall Street Analysts Forecast Growth
Several research firms recently commented on CNC. Jefferies Financial Group lowered Centene from a “hold” rating to an “underperform” rating and dropped their target price for the company from $68.00 to $52.00 in a report on Tuesday, December 10th. Stephens dropped their price objective on Centene from $75.00 to $73.00 and set an “equal weight” rating on the stock in a report on Friday, December 13th. UBS Group upgraded Centene from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $79.00 to $80.00 in a research note on Friday, December 13th. Robert W. Baird increased their price target on shares of Centene from $66.00 to $71.00 in a research note on Tuesday, February 4th. Finally, Barclays boosted their price objective on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a research report on Friday, December 13th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $79.92.
Check Out Our Latest Analysis on CNC
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Recommended Stories
- Five stocks we like better than Centene
- About the Markup Calculator
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- What is diluted earnings per share (Diluted EPS)?
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.